The Minister of Health of the Republic of Kosovo, Armend Zemaj, has approved today the proposal of the professional group of the Kosovo Agency for Medical Products and Equipment (AMPE) that for the implementation of special measures, AMP must issue an import license without marketing authorization for products for use in patients with Covid-19, such as: Remdesivir, Favipiravir and Hydroxychloroquine.
